Original Articles·Operation, How to Do It
Application value of laparoscopic pancreatic tumor enucleation
Zhang Shubin, Zhou Xinbo, Qin Jianzhang, Hu Zixuan, Xing Zhongqiang, Liu Jianhua
Published 2023-04-20
Cite as Chin J Dig Surg, 2023, 22(4): 541-545. DOI: 10.3760/cma.j.cn115610-20230302-00089
Abstract
ObjectiveTo investigate the application value of laparoscopic pancreatic tumor enucleation (LapEN).
MethodsThe retrospective and descriptive study was conducted. The clinical data of 47 patients who underwent LapEN in Second Hospital of Hebei Medical University from September 2016 to June 2022 were collected. There were 18 males and 29 females, aged (49±12)years. Observa-tion indicators: (1) surgical situations; (2) postoperative complications; (3) postoperative recovery; (4) follow-up. Measurement data with normal distribution were represented as Mean±SD, and measurement data with skewed distribution were represented as M(Q1,Q3) or M(range). Count data were described as absolute numbers.
Results(1) Surgical situations. All 47 patients underwent LapEN successfully, with the operation time as (135±19)minutes and the volume of intraoperative blood loss as 100(50,100)mL. (2) Postoperative complications. Of the 47 patients, there were 12 patients with postoperative pancreatic fistula, 3 patients with postoperative abdominal infection, 1 case with postoperative hemorrhage, 1 case with postoperative gastric emptying disorder. (3) Postoperative recovery. Of the 47 patients, there were 13 cases with pancreatic solid pseudopapillary neoplasm, 12 cases with insulinoma, 11 cases with pancreatic serous cystadenoma, 7 cases with pancreatic intraductal papillary mucinous neoplasm (branched type), 4 cases with pancreatic mucinous cyst-adenoma. The tumor diameter of 47 patients was 1.9(1.6,2.3)cm and all patients with R0 resection. There was no patient with perioperative death in the 47 patients. The postoperative duration of hospital stay and total hospital expenses of 47 patients was (13±4)days and (6.8±1.2) ten thousand yuan, respectively. (4) Follow-up. All 47 patients were followed up for 14(range, 8‒18)months. None of the 47 patients had new onset diabetes or situations required postoperative exocrine replacement therapy, and no patient died.
ConclusionLapEN is safe and feasible for patients with pancreatic benign tumor or low potential malignancy.
Key words:
Pancreatic neoplasms; Benign; Pancreatic low potential malignancy; Post-operative pancreatic fistula; Laparoscopy
Contributor Information
Zhang Shubin
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
Zhou Xinbo
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
Qin Jianzhang
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
Hu Zixuan
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
Xing Zhongqiang
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
Liu Jianhua
Department of Hepatobiliary Surgery, Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
